{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:30:43Z","timestamp":1791325843111,"version":"4.3.1"},"reference-count":64,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,5,4]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Pirfenidone ameliorates cGVHD in murine models with distinct pathophysiology. The efficacy of pirfenidone is associated with inhibition of macrophage infiltration and TGF-\u03b2 production.<\/jats:p>","DOI":"10.1182\/blood-2017-01-758854","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T02:20:27Z","timestamp":1488507627000},"page":"2570-2580","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":148,"title":["Pirfenidone ameliorates murine chronic GVHD through inhibition of macrophage infiltration and TGF-\u03b2 production"],"prefix":"10.1182","volume":"129","author":[{"given":"Jing","family":"Du","sequence":"first","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Paz","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Flynn","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ante","family":"Vulic","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara M.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie E.","family":"Lineburg","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute, Brisbane, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie A.","family":"Alexander","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute, Brisbane, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Meng","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabita","family":"Roy","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Panoskaltsis-Mortari","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Loschi","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey R.","family":"Hill","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute, Brisbane, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Serody","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Maillard","sequence":"additional","affiliation":[{"name":"Life Sciences Institute, Center for Stem Cell Biology, University of Michigan, Ann Arbor, MI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Miklos","sequence":"additional","affiliation":[{"name":"Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Koreth","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey S.","family":"Cutler","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[{"name":"Dana-Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli P.","family":"MacDonald","sequence":"additional","affiliation":[{"name":"QIMR Berghofer Medical Research Institute, Brisbane, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Schacker","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Luznik","sequence":"additional","affiliation":[{"name":"Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111903201500200_B1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","article-title":"Current issues in chronic graft-versus-host disease","volume":"124","author":"Soci\u00e9","year":"2014","journal-title":"Blood"},{"issue":"280","key":"2019111903201500200_B2","doi-asserted-by":"crossref","first-page":"280rv2","DOI":"10.1126\/scitranslmed.aaa6853","article-title":"Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation","volume":"7","author":"McDonald-Hyman","year":"2015","journal-title":"Sci Transl Med"},{"issue":"12","key":"2019111903201500200_B3","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.bbmt.2010.06.015","article-title":"Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD","volume":"16","author":"Wolff","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2019111903201500200_B4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbmt.2007.12.002","article-title":"Murine models of chronic graft-versus-host disease: insights and unresolved issues","volume":"14","author":"Chu","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2019111903201500200_B5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1242\/dmm.006668","article-title":"Mouse models of graft-versus-host disease: advances and limitations","volume":"4","author":"Schroeder","year":"2011","journal-title":"Dis Model Mech"},{"issue":"1","key":"2019111903201500200_B6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2016-06-686618","article-title":"Chronic graft-versus-host disease: biological insights from preclinical and clinical studies","volume":"129","author":"MacDonald","year":"2017","journal-title":"Blood"},{"issue":"25","key":"2019111903201500200_B7","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2016-02-699082","article-title":"Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?","volume":"127","author":"Zeiser","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2019111903201500200_B8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2019111903201500200_B9","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2011-07-364414","article-title":"Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans","volume":"119","author":"Srinivasan","year":"2012","journal-title":"Blood"},{"issue":"25","key":"2019111903201500200_B10","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1182\/blood-2014-03-562231","article-title":"Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans","volume":"123","author":"Flynn","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2019111903201500200_B11","first-page":"1","article-title":"CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease","volume":"13","author":"Alexander","year":"2014","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111903201500200_B12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4049\/jimmunol.0903006","article-title":"STAT3 signaling in CD4+ T cells is critical for the pathogenesis of chronic sclerodermatous graft-versus-host disease in a murine model","volume":"184","author":"Radojcic","year":"2010","journal-title":"J Immunol"},{"issue":"5","key":"2019111903201500200_B13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/A:1007068313370","article-title":"Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation","volume":"24","author":"Iyer","year":"2000","journal-title":"Inflammation"},{"issue":"1","key":"2019111903201500200_B14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-3565(24)35110-9","article-title":"Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis","volume":"291","author":"Iyer","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2019111903201500200_B15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-3565(24)38125-X","article-title":"Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis","volume":"289","author":"Iyer","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"2019111903201500200_B16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3181\/00379727-216-44187","article-title":"Pirfenidone attenuates bleomycin-induced changes in pulmonary functions in hamsters","volume":"216","author":"Schelegle","year":"1997","journal-title":"Proc Soc Exp Biol Med"},{"issue":"6","key":"2019111903201500200_B17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.20041393","article-title":"Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis","volume":"201","author":"Abdollahi","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"2019111903201500200_B18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12891-016-1326-y","article-title":"Anti-fibrotic action of pirfenidone in Dupuytren\u2019s disease-derived fibroblasts","volume":"17","author":"Zhou","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"issue":"10","key":"2019111903201500200_B19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.healun.2004.11.002","article-title":"Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts","volume":"24","author":"Zhou","year":"2005","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"2019111903201500200_B20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1600-6143.2005.00876.x","article-title":"Pirfenidone inhibits lung allograft fibrosis through L-arginine-arginase pathway","volume":"5","author":"Liu","year":"2005","journal-title":"Am J Transplant"},{"issue":"2 Pt 1","key":"2019111903201500200_B21","first-page":"L311","article-title":"Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level","volume":"276","author":"Gurujeyalakshmi","year":"1999","journal-title":"Am J Physiol"},{"issue":"1-2","key":"2019111903201500200_B22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1007023532508","article-title":"Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals","volume":"204","author":"Misra","year":"2000","journal-title":"Mol Cell Biochem"},{"issue":"1-3","key":"2019111903201500200_B23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","article-title":"Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis","volume":"590","author":"Oku","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"2019111903201500200_B24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.intimp.2008.01.013","article-title":"Effects of three anti-TNF-alpha drugs: etanercept, infliximab and pirfenidone on release of TNF-alpha in medium and TNF-alpha associated with the cell in vitro","volume":"8","author":"Grattendick","year":"2008","journal-title":"Int Immunopharmacol"},{"issue":"22","key":"2019111903201500200_B25","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111903201500200_B26","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s13075-014-0510-4","article-title":"Pirfenidone gel in patients with localized scleroderma: a phase II study","volume":"16","author":"Rodr\u00edguez-Castellanos","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"2019111903201500200_B27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood-2016-08-693507","article-title":"How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"129","author":"Williams","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2019111903201500200_B28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-versus-host disease","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111903201500200_B29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.stem.2014.11.010","article-title":"Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy","volume":"15","author":"Bruedigam","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2019111903201500200_B30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/infdis\/jiu519","article-title":"Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapy","volume":"211","author":"Estes","year":"2015","journal-title":"J Infect Dis"},{"issue":"7","key":"2019111903201500200_B31","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/rccm.200702-335OC","article-title":"A new murine model for bronchiolitis obliterans post-bone marrow transplant","volume":"176","author":"Panoskaltsis-Mortari","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2019111903201500200_B32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1189\/jlb.1211604","article-title":"Directed migration of mouse macrophages in vitro involves myristoylated alanine-rich C-kinase substrate (MARCKS) protein","volume":"92","author":"Green","year":"2012","journal-title":"J Leukoc Biol"},{"issue":"1","key":"2019111903201500200_B33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1465-9921-8-63","article-title":"Invasive and noninvasive methods for studying pulmonary function in mice","volume":"8","author":"Glaab","year":"2007","journal-title":"Respir Res"},{"issue":"5","key":"2019111903201500200_B34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/pupt.2002.0367","article-title":"Pirfenidone: A novel anti-fibrotic agent and progressive chronic allograft rejection","volume":"15","author":"Dosanjh","year":"2002","journal-title":"Pulm Pharmacol Ther"},{"issue":"10","key":"2019111903201500200_B35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nrd3810","article-title":"Targeting the TGF\u03b2 signalling pathway in disease","volume":"11","author":"Akhurst","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"2019111903201500200_B36","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood-2005-01-0062","article-title":"TGF-beta in allogeneic stem cell transplantation: friend or foe?","volume":"106","author":"Banovic","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2019111903201500200_B37","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.4049\/jimmunol.1201682","article-title":"Cutting edge: intravascular staining redefines lung CD8 T cell responses","volume":"189","author":"Anderson","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"2019111903201500200_B38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nprot.2014.005","article-title":"Intravascular staining for discrimination of vascular and tissue leukocytes","volume":"9","author":"Anderson","year":"2014","journal-title":"Nat Protoc"},{"issue":"12","key":"2019111903201500200_B39","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1172\/JCI39717","article-title":"Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice","volume":"119","author":"Bedoret","year":"2009","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111903201500200_B40","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nm.2356","article-title":"The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling","volume":"17","author":"Doherty","year":"2011","journal-title":"Nat Med"},{"issue":"6","key":"2019111903201500200_B41","doi-asserted-by":"crossref","first-page":"F676","DOI":"10.1152\/ajprenal.00507.2012","article-title":"Pirfenidone inhibits macrophage infiltration in 5\/6 nephrectomized rats","volume":"304","author":"Chen","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"2019111903201500200_B42","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J Immunol"},{"issue":"17","key":"2019111903201500200_B43","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood-2015-10-678706","article-title":"Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism","volume":"127","author":"Flynn","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2019111903201500200_B44","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2003-08-2708","article-title":"A critical role for CCR2\/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation","volume":"103","author":"Hildebrandt","year":"2004","journal-title":"Blood"},{"issue":"3","key":"2019111903201500200_B45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","article-title":"Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?","volume":"50","author":"Murata","year":"2008","journal-title":"J Dermatol Sci"},{"issue":"4","key":"2019111903201500200_B46","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","article-title":"Cell adhesion molecules regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model","volume":"185","author":"Yoshizaki","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"2019111903201500200_B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.86660","article-title":"Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease","volume":"1","author":"Li","year":"2016","journal-title":"JCI Insight"},{"issue":"12","key":"2019111903201500200_B48","doi-asserted-by":"crossref","first-page":"e50896","DOI":"10.1371\/journal.pone.0050896","article-title":"Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation","volume":"7","author":"van der Waart","year":"2012","journal-title":"PLoS One"},{"issue":"1 Suppl","key":"2019111903201500200_B49","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.bbmt.2011.10.001","article-title":"The IL-17 differentiation pathway and its role in transplant outcome","volume":"18","author":"Serody","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"2019111903201500200_B50","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.4049\/jimmunol.168.6.3088","article-title":"Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation","volume":"168","author":"Zhang","year":"2002","journal-title":"J Immunol"},{"issue":"1 Suppl","key":"2019111903201500200_B51","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.bbmt.2011.10.021","article-title":"Fibrotic and sclerotic manifestations of chronic graft-versus-host disease","volume":"18","author":"Kitko","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111903201500200_B52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1465-9921-15-16","article-title":"Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis","volume":"15","author":"Inomata","year":"2014","journal-title":"Respir Res"},{"issue":"10","key":"2019111903201500200_B53","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1248\/bpb.b13-00452","article-title":"Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for idiopathic pulmonary fibrosis","volume":"36","author":"Togami","year":"2013","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"2019111903201500200_B54","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bdd.311","article-title":"Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration","volume":"23","author":"Giri","year":"2002","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"2019111903201500200_B55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/SAP.0b013e31824ba4fd","article-title":"Re: a controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients [letter]","volume":"69","author":"Freshwater","year":"2012","journal-title":"Ann Plast Surg"},{"issue":"4","key":"2019111903201500200_B56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2257.2005.00699.x","article-title":"Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation","volume":"27","author":"Wechalekar","year":"2005","journal-title":"Clin Lab Haematol"},{"issue":"7","key":"2019111903201500200_B57","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Miklos","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111903201500200_B58","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/TP.0b013e3181ae3392","article-title":"Pirfenidone inhibits T-cell activation, proliferation, cytokine and chemokine production, and host alloresponses","volume":"88","author":"Visner","year":"2009","journal-title":"Transplantation"},{"issue":"4","key":"2019111903201500200_B59","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00007890-200202270-00002","article-title":"Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance","volume":"73","author":"Yasufuku","year":"2002","journal-title":"Transplantation"},{"issue":"11","key":"2019111903201500200_B60","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1172\/JCI28031","article-title":"IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants","volume":"117","author":"Burlingham","year":"2007","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111903201500200_B61","doi-asserted-by":"crossref","first-page":"L401","DOI":"10.1152\/ajplung.00080.2012","article-title":"IL-17 induces type V collagen overexpression and EMT via TGF-\u03b2-dependent pathways in obliterative bronchiolitis","volume":"304","author":"Vittal","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"2019111903201500200_B62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.jid.5700517","article-title":"Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma","volume":"127","author":"Zhou","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"8","key":"2019111903201500200_B63","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/TP.0b013e3181f2c92b","article-title":"Effects of pravastatin on murine chronic graft-versus-host disease","volume":"90","author":"Yoon","year":"2010","journal-title":"Transplantation"},{"issue":"4","key":"2019111903201500200_B64","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1172\/JCI200112214","article-title":"Critical role for the chemokine MCP-1\/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome","volume":"108","author":"Belperio","year":"2001","journal-title":"J Clin Invest"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/18\/2570\/1400441\/blood758854.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/18\/2570\/1400441\/blood758854.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T23:38:47Z","timestamp":1750030727000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/18\/2570\/36274\/Pirfenidone-ameliorates-murine-chronic-GVHD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,4]]},"references-count":64,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,5,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-01-758854","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,4]]}}}